No retraction, correction or concern found when last checked on Nov 3, 2026.
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
Ryan A. Flynn, Julia A. Belk, Yanyan Qi and 16 more
Cell · 2021 · CC BY
doi:10.1016/j.cell.2021.03.012
Abstract
SARS-CoV-2 is the cause of a pandemic with growing global mortality. Using comprehensive identification of RNA-binding proteins by mass spectrometry (ChIRP-MS), we identified 309 host proteins that bind the SARS-CoV-2 RNA during active infection. Integration of this data with ChIRP-MS data from three other RNA viruses defined viral specificity of RNA-host protein interactions. Targeted CRISPR screens revealed that the majority of functional RNA-binding proteins protect the host from virus-induced cell death, and comparative CRISPR screens across seven RNA viruses revealed shared and SARS-specific antiviral factors. Finally, by combining the RNA-centric approach and functional CRISPR screens, we demonstrated a physical and functional connection between SARS-CoV-2 and mitochondria, highlighting this organelle as a general platform for antiviral activity. Altogether, these data provide a comprehensive catalog of functional SARS-CoV-2 RNA-host protein interactions, which may inform studies to understand the host-virus interface and nominate host pathways that could be targeted for therapeutic benefit.
Cited by papers we hold 4
- Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection · 2022No notice
- Long COVID: mechanisms, risk factors and recovery · 2022No notice
- Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions · 2021Not checked
- The architecture of the SARS-CoV-2 RNA genome inside virion · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.